Does SaaS Fit into the Complex World of Pharma? (Analyst Opinion)

Publication Date	January 2009
Publisher	Datamonitor
Product Type	Report
Pages	4
ISBN Number	not applicable
Product Code	DAT14425

Buy this product or for assistance call +44 20 7060 7474

PDF £90.00$150 | €101

FAX Order above formats by FAX

Summary

Introduction
SaaS is one of the latest trends in the IT industry, but the new delivery model still has a ways to go before it becomes pervasive in the life sciences.

Scope

Highlights

the factors driving and impeding the uptake of SaaS in pharma

Analyzes the demand for SaaS across the life science product lifecycle

Discusses the strategy vendors should take in introducing SaaS to the pharma industry

Highlights

Recent cost-cutting tactics on the part of pharma executives have vendors wondering if this is the spark needed to introduce SaaS and its potential cost benefits into the highly complex industry.

Widespread implementation of SaaS in the life sciences requires IT systems to be commodity-like rather than niche. Hence, SaaS-based CRM will have a place in the pharma world. On the other hand, SaaS is not suitable for technologies that support the more creative and dynamic world of R&D.

While acceptance and request for SaaS will not be overnight, vendors should not sit back and wait for companies to approach them. Vendors must take this time to evaluate where in the pharma product lifecycle SaaS would be most beneficial and begin the development process for these IT solutions.